These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis. Lahfa M, Mrowietz U, Koenig M, Simon JC. Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986 [Abstract] [Full Text] [Related]
7. Tolerance to calcitriol and tacalcitol in three patients with allergic contact dermatitis to calcipotriol. Foti C, Carnimeo L, Bonamonte D, Conserva A, Casulli C, Angelini G. J Drugs Dermatol; 2005; 4(6):756-9. PubMed ID: 16302563 [Abstract] [Full Text] [Related]
8. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy. Abramovits W. J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032 [Abstract] [Full Text] [Related]
9. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting. van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW. Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431 [Abstract] [Full Text] [Related]
10. Calcipotriol ointment versus cream in psoriasis vulgaris. Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J. Int J Clin Pharmacol Res; 2003 Oct; 23(2-3):47-51. PubMed ID: 15018018 [Abstract] [Full Text] [Related]
11. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g. Calzavara-Pinton P, Rossi MT, Sala R, Venturini M. G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396 [Abstract] [Full Text] [Related]
12. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris. Miyachi Y, Ohkawara A, Ohkido M, Harada S, Tamaki K, Nakagawa H, Hori Y, Nishiyama S. Eur J Dermatol; 2002 Aug; 12(5):463-8. PubMed ID: 12370136 [Abstract] [Full Text] [Related]
16. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Langner A, Ashton P, Van De Kerkhof PC, Verjans H. Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430 [Abstract] [Full Text] [Related]
17. Comparative evaluation of efficacy and safety of calcipotriol versus tacalcitol ointment, both in combination with NBUVB phototherapy in the treatment of stable plaque psoriasis. Dua I, Aggarwal K, Jain VK. Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):275-281. PubMed ID: 28602032 [Abstract] [Full Text] [Related]
18. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience. Lecha M, Mirada A, López S, Artés M, T.O.P. Research Group. J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284 [Abstract] [Full Text] [Related]
19. Delayed-type reactivity to calcipotriol without cross-sensitization to tacalcitol. Zollner TM, Ochsendorf FR, Hensel O, Thaci D, Diehl S, Kalveram CM, Boehncke WH, Wolter M, Kaufmann R. Contact Dermatitis; 1997 Nov; 37(5):251. PubMed ID: 9412768 [No Abstract] [Full Text] [Related]